BEACON: FOR RARE DISEASES LTD

Registered charity 1149646 · accounts filings on the Charity Commission register · also known as FINDACURE FOUNDATION

Findacure works to:Empower patient groups to build their patient community, develop as a charity, and drive treatment research and development.Promote collaboration between rare disease stakeholders to facilitate treatment development for all.

Causes: General Charitable Purposes · Education/training · The Advancement Of Health Or Saving Of Lives · Disability · website · Get email alerts

Latest income
£691k
Latest spending
£662k
Registered
2012
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity ended the year with a surplus of £29,318 and total funds of £220,802, supported by three long-term funding streams. However, the trustees report that the general unrestricted funds of £67,966 are below the stated policy target of three months' staff costs, which they estimate at a little over £100,000.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: Grant funding from UKRI (62% of income)
“The principal funding source in this period was grant funding from the UKRI to support our work on the REMEDi4ALL project. This grant is paid in arears, with payments to Beacon during this period covering work from December 2023 to November 2024 and totaling £157,773.04.” — page 9
Per its FY2025 accounts as filed with the Charity Commission.
Reserves position: below the charity's own stated reserves policy (held: £68k; policy: three months)
“The general unrestricted funds, which the Trustees have not designated, of £67,966 (2024: £74,613) are below the cost of maintaining our staff team for three months (a little over £100,000)”
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Funders the charity credits

Named as funders/supporters on the charity’s own website (the charity’s claim, distinct from accounts-verified grants).

Public profiles (found on the charity’s own website): facebook · instagram

Structured financials (annual return, FY ending 31/01/2025)

Total income
£691k
Total spending
£662k
Cost of raising funds
£52k
Reserves (reported)
£64k
Employees
11

Reported reserves equal ~1.2 months of spending — in the bottom quarter for charities its size (median 5.2 months; benchmarks).

Per its annual return, largest income source: Charitable activities (62% of income) — components as reported reconcile to the return’s total income; not from the accounts narrative.

Per its annual return, cost of raising funds: 7.6% of total income — above the median for charities its size (4.9%) (benchmarks).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/01/2025£691k£662k
31/01/2024£523k£479k
31/01/2023£324k£390k
31/01/2022£270k£318k
31/01/2021£325k£196k

Common questions

Is BEACON: FOR RARE DISEASES LTD financially healthy?

Per its FY2025 accounts: The accounts state that the charity ended the year with a surplus of £29,318 and total funds of £220,802, supported by three long-term funding streams. However, the trustees report that the general unrestricted funds of £67,966 are below the stated policy target of three months' staff costs, which they estimate at a little over £100,000. Its FY2025 accounts were independently examined.

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).

FunderDateAmountPurpose
The National Lottery Community Fund07/05/2024£20kThe Cambridge Rare Disease Showcases
The National Lottery Community Fund17/02/2023£10kThe Rare Disease Showcase Series 2023
The National Lottery Community Fund20/01/2023£404kThe Empowerment Programme: Phase 2
UK government04/08/2022£151kBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
UK government04/08/2022£146kBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
UK government01/04/2022£76kBUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
The National Lottery Community Fund28/10/2021£10kThe Rare Disease Showcase Series 2022
The National Lottery Community Fund22/04/2020£10kThe Showcase Series
The National Lottery Community Fund18/04/2019£337kEmpowerment Programme
The National Lottery Community Fund21/10/2015£28kDrug Repurposing for Rare Diseases
The National Lottery Community Fund28/01/2015£10kTraining Videos for Rare Disease Patient Groups